iQure Pharma Inc. — Form D
iQure Pharma Inc. of SKILLMAN, NJ, a company, filed a Form D exempt-offering notice with the SEC on 2025-01-16. The offering totals $1.4M, of which $1.4M was reported sold. Industry: Other.
Offering
- Filed: 2025-01-16
- Form: D
- Accession: 0001996977-25-000001
- Industry: Other
- Exemptions: 06b
- Total offering: $1.4M
- Amount sold: $1.4M
- Investors: 2
- Date of first sale: 2024-12-20
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-535390
Issuer
- Name: iQure Pharma Inc.
- CIK: 0001996977
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2019
- Address: 3 KITTANSETT COURT, SKILLMAN, NJ, 08558
- Phone: 3122911382
Officers, directors & promoters (2)
| Name | Role | Location |
|---|
| Pawel Zolnierczyk | Executive Officer | SKILLMAN, NJ |
| Pawel Zolnierczyk | Related Person | SKILLMAN, NJ |
Other filings by this issuer (4)
More